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Waardenburg syndrome (WS) 
is an inherited disorder in 
which patients exhibit varying 
combinations of sensorineural 
hearing loss and abnormal 
pigmentation of the eyes, hair and skin.[1-4] 
WS is clinically heterogeneous and has been 
classified into four major types. Type I (WS1, 
MIM 193500) is characterised by deafness, 
dystopia canthorum, a broad nasal root, 
synophrys, hypoplasia of the alae nasi, and 
pigmentation abnormalities (heterochromia 
iridis, white forelock, depigmented skin 
patches);[3,4] type II (WS2, MIM 193510) 
presents like WS1, but without dystopia 
canthorum;[3,4] type III (WS3, MIM 148820), 
also known as Klein-Waardenburg syndrome, 
is an extreme presentation of WS1, manifesting 
with upper-limb abnormalities (e.g. hypo-
plasia, syndactyly);[3,4] and type IV (WS4, 
MIM 277580), also called Shah-Waardenburg 
syndrome or Waardenburg-Hirschsprung 
disease, combines pigmentation defects, deaf-
ness and Hirschsprung’s disease.[3,4]
Types I and II are the most common, types 
IV and III being less frequent and very rare, 
respectively.[5] Overall it is estimated that 
between 1:20 000 and 1:40 000 people have 
WS, and there is a 1.43% prevalence among 
the congenitally deaf.[3,6]
Published data on deafness of genetic 
origin in sub-Saharan Africa are few and old. 
We recently carried out an aetiological survey 
on childhood deafness in Cameroon. [7] In the 
present article we report on the prevalence of 
WS and clinical and audiometric character-
istics of the affected patients.
Methods
The study was approved by the National 
Ethics Committee of Cameroon (No. 123/
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Fig. 1. Waardenburg syndrome in Cameroonian children. (A) Isochromic sapphire-blue eyes. (B) Segmental 
heterochromia iridis: sapphire-blue eyes with a little brown segment. (C) Complete heterochromia iridis. 
(D) Large hypopigmentated area of the trunk.
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CNE/SE/2010). Written informed consent was obtained from 
participants aged ≥18 years, and from parents or guardians of children 
aged <18 years, with assent from the child.
The study on causes of childhood hearing loss was carried out on 582 
Cameroonians recruited in seven of the ten regions of Cameroon. Full 
details of clinical assessment and investigation procedures have been 
published elsewhere.[7] 
Specifically, two classic characteristics of WS were used as diagnostic 
criteria: deafness and pigmentation abnormalities (heterochromia iridis, 
white forelock and depigmented skin patches). In addition, to identify 
dystopia canthorum, a sign of WS1, we calculated the W-index. Using 
a rigid ruler held against the face, we measured (in mm) the inner 
canthal distance (a), the interpupillary distance (b) and the outer canthal 
distance (c). We then calculated:
X = (2a – (0.2119c + 3.909))/c
Y = (2a – (0.2479b + 3.909))/b
W = X + Y + a/b
There is dystopia canthorum if the W-index is ≥1.95.[8] 
Hearing levels were classified in accordance with recommendation 
number 02/1 of the Bureau International d’Audiophonologie, Belgium.[9]
Results
Frequency of WS 
Of 582 patients with hearing loss, 86 (14.8%) had deafness of putative 
genetic origin, 12 cases being genetic syndromic deafness. We found 
six patients (three males and three females) with WS, representing 1% 
of the whole sample, 7% of genetic cases and 50% of genetic syndromic 
cases. 
Clinical and audiological ndings
Two of the patients with WS had a pedigree displaying autosomal 
dominant inheritance, each with an affected parent. The other 
patients had no close relatives with any features of WS, and hence 
appeared to be de novo cases. All the patients with WS were born to 
non-consanguineous parents.
The clinical features are summarised in Table 1 and illustrated 
in Fig. 1. All the patients had normal psychomotor development, 
and none had Hirschsprung’s disease or limb malformations. The 
W-index was <1.95 in all the patients, so in the absence of dystopia 
canthorum they were all classified as having WS2. 
Management
Before enrolment, five of the six patients had never consulted 
an otorhinolaryngologist because of financial limitations and 
the absence of such a specialist in their towns; they had also not 
received prior genetic consultation. Furthermore, none had a 
hearing aid or cochlear implant. Five attended nursery schools or 
primary schools for the deaf, while one, aged 25 years, attended 
a secondary school for normal-hearing pupils despite his severe 
hearing loss. 
Table 1. Clinical and audiological ndings in patients with Waardenburg syndrome
Patient Gender Age (years) WS type Hearing loss
Pigmentation anomalies
InheritanceEyes Skin Hair








areas on the face and 
the trunk
Normal AD








areas on the face
Normal Sporadic
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Normal AD








with a little brown 
segment in le eye
Normal Normal Sporadic




















areas on the face, the 
trunk and the limbs
Normal Sporadic
WS = Waardenburg syndrome; M = male; F = female; AD = autosomal dominant; WS2 = Waardenburg syndrome type II.
Discussion
WS was the most frequent genetic syndrome found in our cohort, 
representing 50% of syndromic cases. This proportion is similar to 
the 62% prevalence of WS among black children with syndromic 
deafness in southern Africa found by Sellars et al.[10] WS could 
therefore be the most frequent form of syndromic deafness in sub-
Saharan African populations. Sellars and Beighton[11] and Hageman[12] 
reported 3% and 1.7% prevalences of WS, respectively, among deaf 
pupils in southern Africa and Kenya – proportions higher than the 
1% reported in this study. These data suggest that the prevalence 
of WS in childhood deafness may vary between 1% and 3% in sub-
Saharan African populations.
We only found WS2 in our population. This finding differs from 
those of other studies in Africa. In their cohorts of patients with WS, 
Hageman[12] and de Saxe et al.[13] reported WS1:WS2 ratios of 18:12 
and 31:21, respectively. Their reports suggest that WS1 may be more 
frequent than WS2. The absence of WS1 in our population seems to 
be a coincidental finding that could be related to poor availability 
of, and access to medical services in some areas of the country. In 
addition, for financial reasons many children with hearing loss may 
not have access to schools for the deaf, and have to choose between 
attending a normal school and not attending school at all. We did 
not find any cases of WS3 and WS4, which are rare in Caucasians.[5] 
The lone report we found of WS4 in Africa was a case in a newborn 
from Morocco.[14] Hirschsprung’s disease, a major feature in WS4, 
accounts for a significant part of the early childhood mortality in 
these patients. In Africa, some patients with WS4 may die before 
diagnosis because of inadequate access to healthcare. 
WS has a very high phenotypic variability.[3] Apart from one 
patient with premature canitis, none of our patients exhibited 
depigmentation of the hair, which has been seen in Nigerian children 
with WS, presenting as white forelock as in Caucasians.[3,15] All of 
our patients had hypoplastic blue eyes, and two of the six had partial 
or complete heterochromia of the iris, which occurs in 21 - 28% of 
patients with WS.[16] 
WS is mainly transmitted as an autosomal dominant trait, but 
can also result from recessive inheritance or de novo occurrence. [3,6] 
Because of the variable phenotype and incomplete penetrance,[3] 
close relatives of affected patients who exhibit very slight features 
may be undiagnosed. Sporadic cases can therefore be de novo, 
autosomal dominant or recessive. 
None of our patients had prior genetic consultation. A medical 
genetic service was recently inaugurated in Cameroon,[17] so genetic 
counselling and molecular studies for deafness will become more 
possible in the country. Given that our patients have WS2, they may 
have mutations on the MTIF, SOX10 and SNAI2 genes.[6] However, 
molecular studies can be ineffective, as 85% of WS2 cases are 
unexplained at the molecular level.[18]
Except for Hirschsprung’s disease in WS4, hearing loss is the 
most important factor in all WS types, because of the impairment of 
quality of life. As congenital deafness is generally diagnosed late in 
sub-Saharan African countries,[7] iris hypoplasia and heterochromia 
iridis are the main clinical features that could enable early diagnosis 
of WS and subsequent investigation for hearing loss. The best 
management for sensorineural hearing loss in childhood is cochlear 
implantation;[19] however, this approach is unfortunately not 
available in Cameroon. 
Conclusion
The results suggest that WS2 is the most common syndromic 
form of hearing loss among Cameroonians. This has implications 
for retrospective genetic counselling and hearing tests for earlier 
management in affected families.
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